The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain

The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain

Parkinson’s Disease (PD) is the second most common neurodegenerative disease worldwide, affecting 1 % of the population over 65 years of age. Dopaminergic cell death in the substantia nigra and accumulation of Lewy bodies are the defining neuropathological hallmarks of the disease. Neuronal death an...

Full description

Bibliographic Details
Main Authors: Normando, Eduardo Maria, Davis, Benjamin Michael, De Groef, Lies, Nizari, Shereen, Turner, Lisa A., Ravindran, Nivedita, Pahlitzsch, Milena, Brenton, Jonathan, Malaguarnera, Giulia, Guo, Li, Somavarapu, Satyanarayana, Cordeiro, Maria Francesca
Format: Online
Language:English
Published: BioMed Central 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989531/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989531/

Similar Items